aminoglutethimide has been researched along with Cancer of Prostate in 64 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinical and biochemical evidence of hypothyroidism (thyrotropin levels greater than 10 mU/L) was noted in nine of 29 patients treated following the initiation of aminoglutethimide (250 mg four times daily)." | 7.69 | Hypothyroidism associated with aminoglutethimide in patients with prostate cancer. ( Calis, KA; Cooper, MR; Figg, WD; Headlee, D; Mays, D; Sartor, AO; Thibault, A, 1994) |
| "Clinical and biochemical evidence of hypothyroidism (thyrotropin levels greater than 10 mU/L) was noted in nine of 29 patients treated following the initiation of aminoglutethimide (250 mg four times daily)." | 3.69 | Hypothyroidism associated with aminoglutethimide in patients with prostate cancer. ( Calis, KA; Cooper, MR; Figg, WD; Headlee, D; Mays, D; Sartor, AO; Thibault, A, 1994) |
| "Forty patients with metastatic adenocarcinoma of the prostate were evaluated for response to treatment with aminoglutethimide plus cortisone acetate." | 3.67 | Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer. ( Chilvers, CE; Dowsett, M; Easton, D; Jeffcoate, SL; Miller, J; Pocock, RD; Ponder, BA; Shearer, RJ, 1984) |
| "Marked leukopenia and/or thrombocytopenia occurred in 12 of 1333 patients treated with aminoglutethimide (0." | 3.67 | Aminoglutethimide-induced hematologic toxicity: worldwide experience. ( Boucher, AE; Buzdar, AU; Harvey, HA; Henderson, IC; Lipton, A; Messeih, AA; Murray, R; Nagel, GA; Ragaz, J; Santen, RJ, 1985) |
| "Management of prostate cancer progression after failure of initial hormonal therapy is controversial." | 2.69 | Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal. ( Bergan, R; Brawley, OW; Cooper, MR; Dawson, N; Figg, WD; Headlee, D; Linehan, WM; Patronas, N; Reed, E; Sartor, O; Sausville, E; Senderowicz, A; Steinberg, SM; Sutherland, M, 1998) |
| "A total of 59 patients with advanced prostate cancer relapsed from or refractory to castration plus oestrogen were treated in a randomised trial comparing 1000 to 1250 mg aminoglutethimide + 40 mg hydrocortisone (AG + HC) with 500 mg medroxyprogesterone acetate + 40 mg hydrocortisone (MPA + HC)." | 2.67 | Treatment of stage D2 prostatic cancer refractory to or relapsed following castration plus oestrogens. Comparison of aminoglutethimide plus hydrocortisone with medroxyprogesterone acetate plus hydrocortisone. ( Bezwoda, WR, 1990) |
| "Eighty-five men with progressive prostate cancer refractory to orchiectomy were treated continuously with aminoglutethimide and hydrocortisone to lower adrenal androgen secretion and were administered cyclic intravenous (IV) chemotherapy." | 2.66 | Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome. ( Bartholomew, M; Boucher, A; Caplan, R; Gordon, R; Harvey, H; Lipton, A; Manni, A; Santen, R; Simmonds, M; White-Hershey, D, 1988) |
| "Seventy-five patients with stage D-2 prostate cancer refractory to orchiectomy have been entered in a controlled trial to test whether androgen priming enhances the efficacy of chemotherapy." | 2.66 | Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer. ( Boucher, AE; Drago, J; Gordon, R; Harvey, H; Lipton, A; Manni, A; Rohner, T; Santen, RJ; Simmonds, M; Wettlaufer, J, 1987) |
| "The term "hormone-refractory" prostate cancer has evolved to include patients with a spectrum of diseases." | 2.39 | Hormone-refractory (D3) prostate cancer: refining the concept. ( Kelly, WK; Scher, HI; Steineck, G, 1995) |
| "Almost all patients with prostatic cancer will eventually escape the control of the first-line endocrine therapy and relapse." | 2.38 | Management of relapsing disease in prostate cancer. ( Denis, L; Mahler, C, 1992) |
| "About one third of patients with breast cancer show objective improvement with aminoglutethimide, and it may also be of use in the treatment of adrenal carcinoma." | 2.37 | Aminoglutethimide and ketoconazole: historical perspectives and future prospects. ( Nicholls, PJ; Shaw, MA; Smith, HJ, 1988) |
| "Flutamide withdrawal, when combined with the simultaneous administration of aminoglutethimide, is a therapeutically active approach in patients with "hormone-refractory" prostate cancer." | 1.29 | Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer. ( Cooper, M; Figg, WD; Headlee, D; Linehan, WM; Myers, CE; Sartor, O; Steinberg, S; Thibault, A; Tompkins, A; Weinberger, M, 1994) |
| "Sections of benign prostatic hyperplasia and prostatic carcinoma from each patient were stained with antibodies to AR and GR using an avidin-biotin peroxidase technique." | 1.29 | Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. ( Chen, Y; Cidlowski, JA; French, FS; Hall, SH; Hamil, K; Mohler, JL; Sar, M; Wilson, EM, 1996) |
| "Ten castrated patients with prostatic cancer received flutamide (FLU) alone for 2 months and, afterwards, the combined therapy of FLU and AG for 2 months." | 1.27 | Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate. ( Bélanger, A; Brochu, M; Cusan, L; Dupont, A; Labrie, F, 1987) |
| "Aminoglutethimide has been used in combination with hydrocortisone in patients with advanced prostatic cancer with the rationale that it causes a 'medical adrenalectomy'." | 1.27 | The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients. ( Dowsett, M; Jeffcoate, SL; Malone, P; Ponder, BA; Shearer, RJ, 1988) |
| "Aminoglutethimide (AG) is a drug that inhibits several steps of steroidogenesis; it is used in post-menopausal advanced breast cancer." | 1.27 | [Aminoglutethimide and cancer of the prostate]. ( Bonneterre, J, 1986) |
| " Drug intervention should be on a regular schedule--avoid prn dosage of pain medications." | 1.27 | Dilemmas in managing prostate carcinoma (Part II): Metastatic disease. ( Ahmann, FR, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (75.00) | 18.7374 |
| 1990's | 14 (21.88) | 18.2507 |
| 2000's | 2 (3.13) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kruit, WH | 1 |
| Stoter, G | 1 |
| Klijn, JG | 1 |
| Hobdy, EM | 1 |
| Shafi, NQ | 1 |
| Kummar, S | 1 |
| Jacobi, GH | 1 |
| Wenderoth, UK | 1 |
| Ponder, BA | 2 |
| Shearer, RJ | 4 |
| Pocock, RD | 1 |
| Miller, J | 1 |
| Easton, D | 1 |
| Chilvers, CE | 1 |
| Dowsett, M | 2 |
| Jeffcoate, SL | 2 |
| Soloway, MS | 1 |
| Drago, JR | 3 |
| Santen, RJ | 5 |
| Lipton, A | 7 |
| Worgul, TJ | 2 |
| Harvey, HA | 3 |
| Boucher, A | 2 |
| Manni, A | 4 |
| Rohner, TJ | 4 |
| Block, M | 1 |
| Trump, D | 1 |
| Rose, DP | 1 |
| Cummings, KB | 1 |
| Hogan, TF | 1 |
| Samojlik, E | 2 |
| Veldhuis, JD | 1 |
| Rostom, AY | 1 |
| Folkes, A | 1 |
| Lord, C | 1 |
| Notley, RG | 1 |
| Schweitzer, FA | 1 |
| White, WF | 1 |
| Shessel, FS | 1 |
| Block, NL | 1 |
| Stover, B | 1 |
| Claflin, A | 1 |
| Malinin, TI | 1 |
| Politano, VA | 1 |
| Robinson, MR | 3 |
| Sartor, O | 3 |
| Cooper, M | 1 |
| Weinberger, M | 1 |
| Headlee, D | 3 |
| Thibault, A | 2 |
| Tompkins, A | 2 |
| Steinberg, S | 1 |
| Figg, WD | 4 |
| Linehan, WM | 2 |
| Myers, CE | 1 |
| Scher, HI | 2 |
| Steineck, G | 1 |
| Kelly, WK | 2 |
| Sartor, AO | 1 |
| Mays, D | 1 |
| Calis, KA | 1 |
| Cooper, MR | 2 |
| Zhang, ZF | 1 |
| Nanus, D | 1 |
| Dawson, N | 2 |
| Middleman, MN | 1 |
| Brawley, O | 1 |
| Lush, RM | 1 |
| Senderowicz, A | 2 |
| Steinberg, SH | 1 |
| Reed, E | 2 |
| Brawley, OW | 1 |
| Bergan, R | 1 |
| Steinberg, SM | 1 |
| Sutherland, M | 1 |
| Patronas, N | 1 |
| Sausville, E | 1 |
| Bare, RL | 1 |
| Torti, FM | 1 |
| Mohler, JL | 1 |
| Chen, Y | 1 |
| Hamil, K | 1 |
| Hall, SH | 1 |
| Cidlowski, JA | 1 |
| Wilson, EM | 1 |
| French, FS | 1 |
| Sar, M | 1 |
| Sanford, EJ | 1 |
| Santen, R | 2 |
| Mahler, C | 1 |
| Denis, L | 1 |
| Dik, P | 1 |
| Blom, JH | 1 |
| Schröder, FH | 1 |
| Abe, K | 1 |
| Adshead, F | 1 |
| De Graeff, A | 1 |
| Mansi, JL | 1 |
| Thomas, DM | 1 |
| Smith, IE | 1 |
| McConnell, JD | 1 |
| Bezwoda, WR | 1 |
| Chang, AY | 1 |
| Bennett, JM | 1 |
| Pandya, KJ | 1 |
| Asbury, R | 1 |
| McCune, C | 1 |
| Vachalovský, V | 2 |
| Vomácka, V | 2 |
| Van Wauwe, JP | 1 |
| Janssen, PA | 1 |
| Labrie, F | 2 |
| Dupont, A | 2 |
| Bélanger, A | 2 |
| Cusan, L | 2 |
| Brochu, M | 2 |
| Turina, E | 1 |
| Pinault, S | 1 |
| Lacourciere, Y | 1 |
| Emond, J | 1 |
| Knönagel, H | 1 |
| Hauri, D | 1 |
| Havlin, KA | 1 |
| Trump, DL | 1 |
| Geller, J | 1 |
| Albert, JD | 1 |
| Sogani, PC | 1 |
| Fair, WR | 1 |
| Shaw, MA | 1 |
| Nicholls, PJ | 1 |
| Smith, HJ | 1 |
| Bartholomew, M | 1 |
| Caplan, R | 1 |
| Harvey, H | 3 |
| Simmonds, M | 3 |
| White-Hershey, D | 2 |
| Gordon, R | 2 |
| Lippman, AJ | 1 |
| Kirschner, MA | 1 |
| Ertel, NH | 1 |
| Park, Y | 1 |
| Szmal, E | 1 |
| Malone, P | 1 |
| Elomaa, I | 1 |
| Taube, T | 1 |
| Blomqvist, C | 1 |
| Rissanen, P | 1 |
| Rannikko, S | 1 |
| Alfthan, O | 1 |
| Melamed, AJ | 1 |
| Boucher, AE | 3 |
| Gordon, RA | 1 |
| Drago, J | 2 |
| Harnett, PR | 1 |
| Raghavan, D | 1 |
| Caterson, I | 1 |
| Pearson, B | 1 |
| Watt, H | 1 |
| Teriana, N | 1 |
| Coates, A | 1 |
| Coorey, G | 1 |
| Nicholson, RI | 1 |
| Walker, KJ | 1 |
| Davies, P | 1 |
| Plowman, PN | 1 |
| Perry, LA | 1 |
| Chard, T | 1 |
| Ahmann, FR | 3 |
| Crawford, ED | 2 |
| Kreis, W | 1 |
| Levasseur, Y | 1 |
| Murray, R | 3 |
| Pitt, P | 2 |
| Davis, MA | 1 |
| Levasseur, YJ | 1 |
| Rohner, T | 1 |
| Wettlaufer, J | 1 |
| Bonneterre, J | 1 |
| Box, M | 1 |
| Saltissi, D | 1 |
| Fawcett, D | 1 |
| Schroeder, FH | 1 |
| Dubost, JJ | 1 |
| Sauvezie, B | 1 |
| Ristori, JM | 1 |
| Thevenet, JP | 1 |
| Rampon, S | 1 |
| Messeih, AA | 1 |
| Ragaz, J | 1 |
| Buzdar, AU | 1 |
| Nagel, GA | 1 |
| Henderson, IC | 1 |
| Blankenstein, MA | 1 |
| Bakker, GH | 1 |
| Bauer, HW | 1 |
| Schmeller, NT | 1 |
| Schmiedt, E | 1 |
| Hendry, WF | 1 |
| Sommerville, IF | 1 |
| Fergusson, JD | 2 |
| Morales, A | 2 |
| Thomas, BS | 1 |
| Connolly, JG | 1 |
| Mobbs, BG | 1 |
| Kraus, A | 1 |
17 reviews available for aminoglutethimide and Cancer of Prostate
| Article | Year |
|---|---|
Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen response in metastatic prostate cancer refractory to standard endocrine therapy.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic C | 2004 |
New forms and future perspectives in endocrine treatment of prostatic carcinoma.
Topics: Aminoglutethimide; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Estrogen Antagonists; Flu | 1984 |
Hormone-refractory (D3) prostate cancer: refining the concept.
Topics: Aminoglutethimide; Clinical Trials as Topic; Cortisone; Dexamethasone; Drug Therapy, Combination; Hu | 1995 |
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer.
Topics: Aminoglutethimide; Androgen Antagonists; Clinical Trials as Topic; Flutamide; Humans; Male; Neoplasm | 1996 |
Endocrine therapy of prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Aminoglutethimide; Androgen Antagonists; Antineoplasti | 1998 |
Aminoglutethimide medical adrenalectomy for advanced prostatic carcinoma.
Topics: Adenocarcinoma; Adrenal Glands; Aged; Aminoglutethimide; Female; Humans; Male; Prostatic Neoplasms | 1976 |
Management of relapsing disease in prostate cancer.
Topics: Aminoglutethimide; Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Estrogens | 1992 |
[Hormone therapy of neoplasms].
Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Med | 1991 |
Physiologic basis of endocrine therapy for prostatic cancer.
Topics: Aminoglutethimide; Androgen Antagonists; Androgens; Estrogens; Gonadotropin-Releasing Hormone; Human | 1991 |
Is there a case for P-450 inhibitors in cancer treatment?
Topics: Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Enzym | 1989 |
Aminoglutethimide: theoretical considerations and clinical results in advanced prostate cancer.
Topics: Adrenal Glands; Aminoglutethimide; Androgens; Humans; Male; Prostatic Neoplasms | 1988 |
Adrenal androgen blockade in relapsed prostate cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Castration; Combined Modality Therapy; Cypro | 1985 |
Treatment of advanced prostatic cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protoco | 1987 |
Aminoglutethimide and ketoconazole: historical perspectives and future prospects.
Topics: Adrenal Gland Neoplasms; Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Femal | 1988 |
Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.
Topics: Aminoglutethimide; Androgen Antagonists; Breast Neoplasms; Estrogen Antagonists; Female; Gonadotropi | 1986 |
Total androgen suppression in the management of prostatic cancer. A critical review.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Castration; Diethylstilbestrol; Dihydrotesto | 1985 |
[New hormonal treatments of metastatic prostatic cancer. Review of the literature].
Topics: Aminoglutethimide; Androgen Antagonists; Animals; Antineoplastic Agents; Combined Modality Therapy; | 1985 |
10 trials available for aminoglutethimide and Cancer of Prostate
| Article | Year |
|---|---|
Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen response in metastatic prostate cancer refractory to standard endocrine therapy.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic C | 2004 |
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Che | 1998 |
Mitomycin C and aminoglutethimide in the treatment of metastatic prostatic cancer: a phase II study.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Humans; | 1992 |
Treatment of stage D2 prostatic cancer refractory to or relapsed following castration plus oestrogens. Comparison of aminoglutethimide plus hydrocortisone with medroxyprogesterone acetate plus hydrocortisone.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Mo | 1990 |
[Orimeten in the treatment of advanced carcinoma of the prostate].
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents; Carcinoma; Cyclophosphamide; Drug | 1989 |
Treatment of advanced prostatic cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protoco | 1987 |
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome.
Topics: Acid Phosphatase; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Clinical | 1988 |
Androgen priming and response to chemotherapy in advanced prostatic cancer.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Clinical | 1986 |
Aminoglutethimide in advanced prostatic carcinoma.
Topics: Aged; Aminoglutethimide; Clinical Trials as Topic; Diethylstilbestrol; Drug Therapy, Combination; Hu | 1987 |
Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Combined Modality | 1987 |
39 other studies available for aminoglutethimide and Cancer of Prostate
| Article | Year |
|---|---|
Prostate cancer metastasis to supraclavicular lymph node.
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Prot | 2004 |
Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Proto | 1984 |
Newer methods of hormonal therapy for prostate cancer.
Topics: Adenocarcinoma; Aminoglutethimide; Androgen Antagonists; Bone Neoplasms; Buserelin; Flutamide; Gonad | 1984 |
Clinical effect of aminoglutethimide, medical adrenalectomy, in treatment of 43 patients with advanced prostatic carcinoma.
Topics: Adenocarcinoma; Adrenalectomy; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protoco | 1984 |
Evaluation of aminoglutethimide in stage D prostate cancer: an assessment of efficacy and toxicity in patients with tumors refractory to hormonal therapy.
Topics: Aminoglutethimide; Antineoplastic Agents; Aspartate Aminotransferases; Drug Evaluation; Electrolytes | 1984 |
Clinical and biochemical effect of aminoglutethimide in the treatment of advanced prostatic carcinoma.
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Bone Neoplasms; Dihydrotestosterone; Drug Therapy, Combinat | 1983 |
Aminoglutethimide therapy for advanced carcinoma of the prostate.
Topics: Aged; Aminoglutethimide; Analgesics; Humans; Male; Middle Aged; Prostatic Neoplasms | 1982 |
Endocrine manipulation of the Dunning prostatic adenocarcinoma.
Topics: Adenocarcinoma; Adrenalectomy; Aminoglutethimide; Animals; Castration; Diethylstilbestrol; Disease M | 1980 |
Aminoglutethimide: medical adrenalectomy in the management of carcinoma of the prostate. A review after 6 years.
Topics: Adrenal Glands; Aminoglutethimide; Drug Evaluation; Follow-Up Studies; Humans; Male; Prostatic Neopl | 1980 |
Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Flutamid | 1994 |
Hypothyroidism associated with aminoglutethimide in patients with prostate cancer.
Topics: Aged; Aminoglutethimide; Diagnosis, Differential; Humans; Hypothyroidism; Male; Prospective Studies; | 1994 |
Flutamide withdrawal and concomitant initiation of aminoglutethimide in patients with hormone refractory prostate cancer.
Topics: Aged; Aminoglutethimide; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Resistance, Neo | 1996 |
Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma.
Topics: Aged; Aminoglutethimide; Epithelial Cells; Humans; Immunohistochemistry; Ketoconazole; Male; Middle | 1996 |
Small cell carcinoma of the prostate: implications for management.
Topics: Adenocarcinoma; Aminoglutethimide; Bone Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubi | 1991 |
A study of aminoglutethemide and hydrocortisone in patients with advanced and refractory prostate carcinoma.
Topics: Aminoglutethimide; Carcinoma; Drug Evaluation; Drug Therapy, Combination; Humans; Hydrocortisone; Ma | 1989 |
Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapy.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Flutam | 1989 |
[The effect of aminoglutethimide on steroid synthesis of the adrenal gland and its use in prostate cancer].
Topics: Adrenal Cortex; Aged; Aged, 80 and over; Aminoglutethimide; Androgens; Combined Modality Therapy; Hu | 1989 |
Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate.
Topics: Aged; Aminoglutethimide; Androstane-3,17-diol; Androstanols; Androsterone; Anilides; Dehydroepiandro | 1987 |
Medical adrenalectomy for advanced prostatic cancer: clinical and hormonal effects.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Androgens; Antineoplastic Combined Chemotherapy Protocol | 1988 |
[Orimeten in the treatment of advanced prostatic carcinoma].
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 1988 |
The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Pr | 1988 |
Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapy.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Bone Neoplasms; Drug Therapy, Combination; Humans; Hydro | 1988 |
Correction: prostate cancer treatment.
Topics: Aminoglutethimide; Humans; Male; Prostatic Neoplasms | 1987 |
Androgen suppression by hydrocortisone without aminoglutethimide in orchiectomised men with prostatic cancer.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Androgen Antagonists; Androgens; Drug Therapy, Combinati | 1987 |
Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone.
Topics: Aminoglutethimide; Androgens; Androstenedione; Drug Therapy, Combination; Humans; Hydrocortisone; Ma | 1987 |
Aminoglutethimide in the treatment of advanced prostatic cancer.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neopla | 1987 |
Aminoglutethimide in metastatic adenocarcinoma of the prostate.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminoglutethimide; Humans; Hydrocortisone; Male; Mid | 1987 |
[Aminoglutethimide and cancer of the prostate].
Topics: Adrenal Glands; Aminoglutethimide; Androgens; Drug Evaluation; Humans; Male; Prostatic Neoplasms | 1986 |
Inappropriate secretion of antidiuretic hormone following aminoglutethimide therapy.
Topics: Aged; Aminoglutethimide; Humans; Inappropriate ADH Syndrome; Male; Prostatic Neoplasms | 1986 |
Dilemmas in managing prostate carcinoma (Part II): Metastatic disease.
Topics: Aged; Aminoglutethimide; Aspirin; Bone Neoplasms; Castration; Diethylstilbestrol; Disseminated Intra | 1985 |
Treatment of advanced prostatic cancer, resistant to conventional therapy, with aminoglutethimide.
Topics: Aged; Aminoglutethimide; Castration; Combined Modality Therapy; Estrogens; Follow-Up Studies; Humans | 1985 |
Aminoglutethimide-induced hematologic toxicity: worldwide experience.
Topics: Aminoglutethimide; Blood Cell Count; Breast Neoplasms; Female; Global Health; Hematologic Diseases; | 1985 |
Rationale for suppression of adrenal steroidogenesis in advanced prostatic cancer.
Topics: Adrenal Cortex Hormones; Aminoglutethimide; Androgen Antagonists; Androgens; Animals; Estrogens; Hum | 1985 |
[Aminoglutethimide in the treatment of advanced prostatic cancer].
Topics: Acid Phosphatase; Aged; Aminoglutethimide; Castration; Combined Modality Therapy; Estradiol; Estradi | 1985 |
Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer.
Topics: Adrenal Glands; Aminoglutethimide; Castration; Circadian Rhythm; Diethylstilbestrol; Estrogens; Estr | 1973 |
Adrenal suppression in the treatment of carcinoma of the prostate.
Topics: Acid Phosphatase; Administration, Oral; Adrenal Glands; Aged; Alkaline Phosphatase; Aminoglutethimid | 1974 |
Steroid biosynthesis and lymphocytotoxic effects in prostatic cancer.
Topics: Aminoglutethimide; Cytotoxicity Tests, Immunologic; Diethylstilbestrol; Glucocorticoids; Humans; Lym | 1972 |
Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma.
Topics: Age Factors; Aged; Aminoglutethimide; Castration; Diethylstilbestrol; Estrogens; Humans; Male; Middl | 1971 |
Effects of aminoglutethimide on the prostate glands of rats--a preliminary study.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Aminoglutethimide; Androgens; Aniline Compounds; Animals; A | 1971 |